Global Security Newswire
Daily News on Nuclear, Biological & Chemical Weapons, Terrorism and Related Issues
FDA Approves Two Antiradiation Injections
The U.S. Food and Drug Administration yesterday approved two drugs that facilitate the elimination of radiation from the body, both designed as antidotes for use following a potential radiological bomb attack (see GSN, July 23).
The two drugs, administered via injection and available only by prescription, are safe and effective for treating contamination from the elements plutonium, americium or curium, according to officials. No drugs for treatment of internal contamination by the three elements have previously been approved in the United States, they added (Associated Press/Yahoo!News, Aug. 11).
Note to our Readers
GSN ceased publication on July 31, 2014. Its articles and daily issues will remain archived and available on NTI’s website.
Remarks to a Joint Conference of NTI and the International Luxembourg Forum on Preventing Nuclear Catastrophe
Dec. 2, 2015
NTI Co-Chairman Sam Nunn addressed U.S. and Russian participants at a joint meeting of the Luxembourg Forum and NTI.
Nov. 19, 2015
NTI Executive Vice President Deborah Rosenblum delivers opening remarks to the Arab Institute for Security Studies (ACSIS) Nuclear Forum.
This article provides an overview of the United States’ historical and current policies relating to nuclear, chemical, biological and missile proliferation.